Recently, Collard et al. [31] noted that serum IL-6 and other biomarkers of type II alveolar epithelial cells (KL-6 and SP-D) were significantly higher among IPF patients with acute exacerbation compared to stable IPF patients and those with acute lung injury. The gene discussed is IL6; the disease is idiopathic pulmonary fibrosis.